Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 23;5(11):e128013.
doi: 10.1172/jci.insight.128013.

Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption

Affiliations

Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption

Justin J Lee et al. JCI Insight. .

Abstract

Plasma calcium (Ca2+) is maintained by amending the release of parathyroid hormone and through direct effects of the Ca2+ sensing receptor (CaSR) in the renal tubule. Combined, these mechanisms alter intestinal Ca2+ absorption by modulating 1,25-dihydroxy vitamin D3 production, bone resorption, and renal Ca2+ excretion. The CaSR is a therapeutic target in the treatment of secondary hyperparathyroidism and hypocalcemia a common complication of calcimimetic therapy. The CaSR is also expressed in intestinal epithelium, however, a direct role in regulating local intestinal Ca2+ absorption is unknown. Chronic CaSR activation decreased expression of genes involved in Ca2+ absorption. In Ussing chambers, increasing extracellular Ca2+ or basolateral application of the calcimimetic cinacalcet decreased net Ca2+ absorption across intestinal preparations acutely. Conversely, Ca2+ absorption increased with decreasing extracellular Ca2+ concentration. These responses were absent in mice expressing a non-functional TRPV6, TRPV6D541A. Cinacalcet also attenuated Ca2+ fluxes through TRPV6 in Xenopus oocytes when co-expressed with the CaSR. Moreover, the phospholipase C inhibitor, U73122, prevented cinacalcet-mediated inhibition of Ca2+ flux. These results reveal a regulatory pathway whereby activation of the CaSR in the basolateral membrane of the intestine directly attenuates local Ca2+ absorption via TRPV6 to prevent hypercalcemia and help explain how calcimimetics induce hypocalcemia.

Keywords: Calcium; Calcium channels; Gastroenterology; Nephrology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: RTA has consulted for Ardylex Inc. and Advicenne Inc.

Figures

Figure 1
Figure 1. Relative intestinal mRNA expression of transcellular Ca2+ transport mediators under altered extracellular Ca2+ conditions.
(AC) Relative mRNA expression of transcellular Ca2+ transport mediators TRPV6 (Trpv6), CABP9K (S100g), NCX1 (Slc8a1), or PMCA1b (Atp2b1), normalized to 18S rRNA expression in mice on high-, normal- (Con), or low-Ca2+ diet for 21 days (n = 7 for each diet). (DF) Relative mRNA expression in animals treated with 1,25-[OH]2 D3 (VD) or vehicle (Veh) (n = 8 for each). (GI) Relative mRNA expression in animals treated with cinacalcet (Cin) or control (Veh) diet (n = 8 for each). All data are presented as the mean ± SEM, normalized to the mice on the normal/control diet. Asterisks indicate a statistically significant difference from the normal/control mice by 1-way ANOVA (all genes in A and Slc8a1 and Atp2b1 in B and C), Brown-Forsythe test (S100g in B), Kruskal-Wallis test (Trpv6 in B and C), or Student’s unpaired t tests (DI); *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 2
Figure 2. Protocol used to measure unidirectional Ca2+ fluxes across intestinal preparations.
The transepithelial voltage across tissue preparations (y axis) was clamped to 0 mV for the duration of the experiment (x axis). The voltage spikes along the x axis correspond to 2-mV pulses applied and used to determine the transepithelial resistance (TER). We added 0.1 μM tetrodotoxin (TTX) basolaterally first and allowed the resulting short-circuit current to stabilize. At time 0, the solutions were exchanged for fresh ones with 1 side spiked with 45Ca2+. Asterisks indicate the time points when samples were taken for radioactivity measurements. Two gray horizontal lines represent 15-minute time intervals, where unidirectional 45Ca2+ flux was calculated for each condition. We added 10 μM forskolin at the end of the experiment to confirm tissue viability.
Figure 3
Figure 3. The effect of altering extracellular Ca2+ on Ca2+ fluxes across mouse proximal colon.
(A) An example of the short-circuit current (ISC) recorded throughout protocol 1. TTX was added and ISC allowed to stabilize. The ISC spikes occurred in response to 2-mV pulses. At the second arrow, solutions were exchanged, with 1 side only containing 45Ca2+. The tissue was deemed viable if the ISC increased more than 3 times with forskolin administration at the end of the experiment. (B) Changes in the net Ca2+ flux (net JCa2+) between condition A, pretreatment (Pre Rx), and condition B, vehicle (ethanol) or 10 μM cinacalcet (n = 6 each treatment). (C) The change in net JCa2+ between condition A, high Ca2+ (2.5 mM), and condition B, low-Ca2+ (0.5 mM), or the converse (n = 6 each). Raw values are presented; asterisks indicate a statistical difference between the conditions (Student’s paired t tests; *P < 0.05, and **P < 0.01).
Figure 4
Figure 4. Expression of the CaSR and effect of apical or basolateral CaSR activation.
(A) Relative mRNA expression of the CaSR throughout mouse intestine (n = 12), normalized to duodenum. (B and C) Changes in the net JCa2+ in the proximal colon of wild-type mice between condition A, pretreatment, and condition B, apical or basolateral 10 μM cinacalcet application (n = 7 each application in B; n = 6 in C). Raw values are presented; asterisks indicate a statistical difference between the conditions (Student’s paired t tests; *P < 0.05).
Figure 5
Figure 5. Effect of extracellular Ca2+ on Ca2+ fluxes across proximal colon from TRPV6WT/WT or TRPV6D541A/D541A mice.
(A) Change in net JCa2+ between condition A, pretreatment, and condition B, basolateral 10 μM cinacalcet application (n = 6 each). (B) Change in net JCa2+ between condition A, high Ca2+ (2.5 mM), and condition B, low Ca2+ (0.5 mM) (n = 6 each). Raw values are presented; asterisks indicate a statistical difference between conditions (Student’s paired t test for within genotype comparisons or unpaired t tests for between genotype comparison; *P < 0.05, and **P < 0.01).
Figure 6
Figure 6. Effect of phospholipase C inhibition on CaSR-mediated inhibition of Ca2+ absorption in in vitro and ex vivo.
(A) Effect of CaSR activation on Ca2+-induced currents (ICa) in TRPV6 expressing oocytes in the presence and absence of cinacalcet and/or U73122, a phospholipase C (PLC) inhibitor (n = 6 each). Mean ICa values obtained from TRPV6- and CaSR-expressing oocytes were normalized to vehicle ICa values from TRPV6-expressing oocytes ± SEM; asterisks indicate a statistically significant difference between the conditions (multiple-comparisons Kruskal-Wallis test; *P < 0.05; **P < 0.01). (B) Effect of cinacalcet and/or U73122 on the plasma membrane expression of TRPV6 and CaSR in oocytes determined by immunoblot. As a loading control, β-actin was blotted (bottom). (C) Quantification of surface TRPV6 expression, normalized to total TRPV6 (n = 3 each). (D) Effect of basolateral cinacalcet (10 μM) and vehicle (DMSO) or PLC inhibitor U73122 (10 μM) on mouse proximal colon (n = 6 each). Raw values are presented; asterisks indicate a statistical difference between the conditions (Student’s paired t tests; *P < 0.05).
Figure 7
Figure 7. Proposed model of CaSR-mediated inhibition of Ca2+ absorption.
(A) Increased plasma Ca2+ is sensed by the CaSR expressed in kidneys, bone, intestine, and parathyroid glands. In response, the kidneys decrease Ca2+ reabsorption, there is decreased bone resorption, and parathyroid hormone (PTH) secretion is decreased. We show herein that intestinal Ca2+ absorption is inhibited. In concert, this reduces plasma Ca2+. Importantly, PTH acts to increase plasma Ca2+ by increasing bone Ca2+ resorption, renal tubular reabsorption, and indirectly by increasing intestinal Ca2+ absorption by increasing 1,25-[OH]2 D3 synthesis in the kidneys. (B) High plasma Ca2+ is detected by the intestinal epithelial basolateral CaSR, which inhibits TRPV6-mediated transcellular Ca2+ transport via PLC.

Similar articles

Cited by

References

    1. Blau JE, Collins MT. The PTH-Vitamin D-FGF23 axis. Rev Endocr Metab Disord. 2015;16(2):165–174. doi: 10.1007/s11154-015-9318-z. - DOI - PubMed
    1. Fleet JC. The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol Cell Endocrinol. 2017;453:36–45. doi: 10.1016/j.mce.2017.04.008. - DOI - PMC - PubMed
    1. Khundmiri SJ, Murray RD, Lederer E. PTH and vitamin D. Compr Physiol. 2016;6(2):561–601. - PMC - PubMed
    1. Rodríguez-Ortiz ME, Rodríguez M. FGF23 as a calciotropic hormone. F1000Res. 2015;4:F1000. - PMC - PubMed
    1. Toka HR, Pollak MR, Houillier P. Calcium sensing in the renal tubule. Physiology (Bethesda) 2015;30(4):317–326. - PubMed

Publication types

MeSH terms